LifeStance Health Prices 35M-Share Offering at $8.15, Plans 6M-Share Repurchase
LifeStance Health Group priced a secondary offering of 35 million shares at $8.15 each, with all proceeds to selling stockholders and no proceeds to the company. The company agreed to repurchase 6 million shares from the underwriter at the same price, subject to customary closing conditions.
1. Offering Details
LifeStance Health Group announced an underwritten secondary public offering of 35,000,000 shares of common stock at a price of $8.15 per share. All proceeds from this sale will go directly to the selling stockholders, with the company itself not receiving any funds from the transaction.
2. Repurchase Agreement
As part of the transaction, LifeStance has committed to purchase 6,000,000 shares from the underwriter at the same $8.15 per share price. This repurchase is conditioned on the offering’s closing and other customary conditions, but the offering itself is not contingent on the repurchase.
3. Settlement Timeline
Subject to customary closing conditions, both the secondary offering and the company’s repurchase are expected to settle on or about May 12, 2026. Investors and underwriters will finalize transactions on that date.
4. Underwriting and Registration
J.P. Morgan is serving as the underwriter for the offering. The shares are being sold under a shelf registration statement that became effective upon filing with the SEC on May 21, 2024.